A long-term study presented at the European Association of Urology Congress in Paris found that an oral spray-based vaccine, MV140, can prevent recurrent urinary tract infections (UTIs) for up to nine years in over half of participants. The vaccine was shown to be safe and effective, with 48% of participants remaining UTI-free during the follow-up period. The researchers suggest that this vaccine could be a game-changer in UTI prevention, offering a potential alternative to antibiotic treatments. Further research is needed to optimize the use of this vaccine and explore its effectiveness in different patient groups.
Source link
Oral vaccine for UTI is potential alternative to antibiotics, finds 9-year study
